Modeling laboratory data from clinical trials

Gerd K. Rosenkranz

Computational Statistics & Data Analysis, 2009, vol. 53, issue 3, 812-819

Abstract: Abnormal laboratory data from clinical trials are considered precursors of potential organ dysfunction. Routine analysis of these data focusses primarily on the incidence of extremely high or low values relative to normal ranges, or the change of these incidences compared to baseline. Alternatively, the worst values from each individual patient are analyzed. Where feasible, graphical representations of the time course of lab measurements are displayed, often for each subject individually. However, only rarely is an attempt made to model the dynamics of the measurements over time. Stochastic processes can be used to model laboratory measurements and specifically Ornstein-Uhlenbeck processes have some properties that are suitable for this purpose. Models based on these processes can account for potential systematic effects relevant for all or a group of subjects as well as the random variation between subjects. The idea is to estimate parameters of these processes in order to quantify effects of drugs or other medical treatments. Results based on simulations and real data will be presented.

Date: 2009
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0167-9473(08)00341-1
Full text for ScienceDirect subscribers only.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:csdana:v:53:y:2009:i:3:p:812-819

Access Statistics for this article

Computational Statistics & Data Analysis is currently edited by S.P. Azen

More articles in Computational Statistics & Data Analysis from Elsevier
Bibliographic data for series maintained by Catherine Liu ().